股票/基金 实时行情 股吧

简称:浙江医药 代码:600216


会计年度:2006-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
VH219,122,241.70156,889,688.7262,232,552.9828.40
本芴醇226,896,236.66187,606,987.7239,289,248.9417.32
辅酶Q10129,042,360.4490,392,794.1838,649,566.2629.95
合成VE系列668,784,557.42631,686,375.6037,098,181.825.55
来立信系列76,397,197.3729,851,994.0146,545,203.3660.93
食品销售187,622.10163,819.30----
天然VE系列85,353,896.7546,946,568.8738,407,327.8845.00
原料药销售1,808,315,366.961,525,123,057.72----
制剂销售491,771,407.18398,482,768.6893,288,638.5018.97

会计年度:2006-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:抵销55,735,624.8655,735,624.86----
食品销售79,894.9068,112.9511,781.9514.75
原料药销售941,029,230.59785,626,230.56155,403,000.0316.51
制剂药销售240,391,097.30187,052,113.3153,338,983.9922.19

会计年度:2005-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
技术转让12,300,000.00------
减:抵销89,737,964.2077,437,964.2012,300,000.0013.71
食品销售9,020,483.287,546,400.551,474,082.7316.34
原料药销售1,486,225,595.061,240,425,003.13245,800,591.9316.54
制剂药销售466,850,613.61340,413,824.69126,436,788.9227.08

会计年度:2005-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:抵销15,327,833.6215,327,833.62----
食品销售6,611,645.305,267,366.651,344,278.6520.33
原料药销售711,492,298.75608,043,847.45103,448,451.3014.54
制剂药销售229,083,811.19164,774,599.2764,309,211.9228.07

会计年度:2004-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
减:抵销7,500,417.067,500,417.06----
食品销售6,404,112.164,973,421.571,430,690.5922.34
原料药销售994,258,311.30920,731,655.3673,526,655.947.40
制剂药销售389,620,833.41276,234,044.45113,386,788.9629.10

    7/9 转到